Waverley Pharma Inc(WAVE-X)
TSX Venture

Today's Change
Delayed Last Update

Waverley Pharma Inc

1250 Waverley Street
Suite 4
Winnipeg MB R3T 6C6 CAN
P: 204-928-7907
F: 204-453-1370
https://www.waverleypharma.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics focused on oncology. The company's product pipeline includes Bortezomib, Pemetrexed, Capecitabine, and Temozolomide, among others. The company operates in one business segment, the biopharmaceutical industry.

    Key Executives

    NameTitle
    Larry ThiessenCEO/Director/President
    Haaris UddinCFO

    More from The Globe

    Nuclear ambitions are stirring again, and could turn this stock around
    Atkins Realis headquarters are seen in Montreal on Wednesday, Sept. 24, 2025. THE CANADIAN PRESS/Christinne Muschi
    The highest-yielding stocks on the TSX, plus risk data
    Un homme passe devant un immeuble de Toronto qui abritait autrefois la Bourse de Toronto, le jeudi 18 août 2011. LA PRESSE CANADIENNE/Aaron Vincent Elkaim
    Outgoing Telus CEO presents sunny view of his tenure, despite stock price challenges
    Darren Entwistle, CEO of Telus, visits The Globe and Mail offices for an editorial board interview. June 19, 2026 (Sarah Espedido/The Globe and Mail)
    the mover
    Why this multi-billion-dollar money manager believes emerging markets are poised for outperformance
    Rohit Khuller, vice-president of investment management at Montreal-based Letko, Brosseau & Associates Inc. Illustration by Joel Kimmel
    Small caps to watch: Aecon buys back interest in utilities business, how much Jamieson Wellness could go for in a takeout, and a warning from Sherritt
    FILE PHOTO: People walk through the Canary Wharf financial district of London, Britain, December 7, 2018. REUTERS/Simon Dawson
    Thursday’s Insider Report: Multiple executives sell shares in this stock that’s doubled in 2026
    Technicians put the final touches on the second of three Radarsat Constellation Mission satellites at the MDA facility Thursday, June 21, 2018 in Montreal.
    Dye & Durham dumps CEO, Tyler Proud now leads company through board committee
    The Bay Street financial district of Toronto is shown on Sunday Sept. 8, 2024. THE CANADIAN PRESS/Doug Ives
    Six bargain stock picks from hedge fund managers
    forex candlestick charts monitored

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.